SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 26th, 2024 • DiaMedica Therapeutics Inc. • Pharmaceutical preparations • New York
Contract Type FiledJune 26th, 2024 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of June 25, 2024, by and among DiaMedica Therapeutics Inc., a corporation existing under the laws of British Columbia, Canada (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser,” and collectively, the “Purchasers”). The Company and the Purchasers are sometimes hereinafter referred to each as a “party” and collectively as the “parties.”
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 22nd, 2023 • BioSig Technologies, Inc. • Electromedical & electrotherapeutic apparatus • New York
Contract Type FiledMay 22nd, 2023 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of May 16, 2023, between BioSig Technologies, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 21st, 2023 • BioSig Technologies, Inc. • Electromedical & electrotherapeutic apparatus • New York
Contract Type FiledApril 21st, 2023 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of April 18, 2023, between BioSig Technologies, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).